MetLife Investment Management LLC Grows Stake in ICU Medical, Inc. (NASDAQ:ICUI)

MetLife Investment Management LLC raised its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 129.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 12,389 shares of the medical instruments supplier's stock after purchasing an additional 6,981 shares during the quarter. MetLife Investment Management LLC owned 0.05% of ICU Medical worth $2,258,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ICUI. CWM LLC raised its stake in shares of ICU Medical by 18.5% during the 2nd quarter. CWM LLC now owns 767 shares of the medical instruments supplier's stock worth $91,000 after buying an additional 120 shares during the period. SG Americas Securities LLC boosted its holdings in ICU Medical by 441.7% in the 2nd quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock worth $691,000 after buying an additional 4,744 shares during the last quarter. Blue Trust Inc. increased its stake in ICU Medical by 384.4% during the 2nd quarter. Blue Trust Inc. now owns 1,090 shares of the medical instruments supplier's stock worth $129,000 after buying an additional 865 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in ICU Medical by 3.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 10,939 shares of the medical instruments supplier's stock worth $1,299,000 after buying an additional 339 shares in the last quarter. Finally, Kirr Marbach & Co. LLC IN lifted its position in shares of ICU Medical by 5.6% in the second quarter. Kirr Marbach & Co. LLC IN now owns 23,809 shares of the medical instruments supplier's stock valued at $2,827,000 after acquiring an additional 1,269 shares in the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Trading Down 0.6 %

Shares of ICUI traded down $0.98 during trading on Thursday, reaching $155.65. 160,373 shares of the company traded hands, compared to its average volume of 272,802. The stock has a 50-day simple moving average of $173.54 and a 200-day simple moving average of $148.49. The stock has a market cap of $3.81 billion, a PE ratio of -34.27 and a beta of 0.62. ICU Medical, Inc. has a twelve month low of $83.26 and a twelve month high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75.

Insider Activity at ICU Medical

In related news, COO Christian B. Voigtlander sold 1,962 shares of the business's stock in a transaction on Monday, November 25th. The stock was sold at an average price of $169.08, for a total transaction of $331,734.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Vivek Jain sold 12,000 shares of the company's stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $162.91, for a total value of $1,954,920.00. Following the sale, the chief executive officer now owns 104,593 shares in the company, valued at approximately $17,039,245.63. This trade represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 40,364 shares of company stock worth $6,869,878. Insiders own 6.70% of the company's stock.

Analyst Ratings Changes

Several analysts recently commented on the company. Jefferies Financial Group started coverage on ICU Medical in a research report on Monday, October 14th. They set a "hold" rating and a $183.00 price target for the company. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. Raymond James boosted their target price on ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a report on Thursday, September 12th. Finally, KeyCorp increased their price target on ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $173.00.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.